109
Participants
Start Date
July 29, 2019
Primary Completion Date
July 13, 2020
Study Completion Date
July 13, 2020
Semaglutide
Solution administered subcutaneously with pre-filled PDS290 pen-injector once weekly
Firsocostat
Tablets administered orally once daily
Cilofexor
Tablets administered orally once daily
Northwell Health, Manhasset
Gastro One, Huntersville
Gastrointestinal Specialists of Georgia, Marietta
Quality Medical Research, PLLC, Nashville
Gastro One, Germantown
The Liver Institute at Methodist Dallas Medical Center, Dallas
Texas Clinical Research Institute, Arlington
American Research Corporation, San Antonio
Institute for Liver Health - Arizona Liver Health, Chandler
Jubilee Clinical Research, Inc., Las Vegas
Ruane Clinical Research Group, Inc, Los Angeles
Cedars Sinai Medical Center, Los Angeles
University of California San Diego (UCSD), La Jolla
Southern California Research Centers, Coronado
Medical Associates Research Group, San Diego
Inland Empire Clinical Trials, LLC, Rialto
Beth Israel Deaconess Medical Center, Boston
University Gastroenterology, Providence
Lead Sponsor
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
Gilead Sciences
INDUSTRY